학술논문
Transcatheter Mitral Repair for Functional Mitral Regurgitation According to Left Ventricular Function: A Real-Life Propensity-Score Matched Study
Document Type
article
Author
Isaac Pascual; Fernando Carrasco-Chinchilla; Tomas Benito-Gonzalez; Chi Hion Li; Pablo Avanzas; Luis Nombela-Franco; Manuel Pan; Ana Serrador Frutos; Xavier Freixa; Ramiro Trillo-Nouche; Rosa A. Hernández-Antolín; Leire Andraka Ikazuriaga; Ignacio Cruz-Gonzalez; Jose R. López-Mínguez; Jose L. Diez; Alberto Berenguer-Jofresa; Juan Sanchis; Valeriano Ruiz-Quevedo; Cristobal Urbano-Carrillo; Juan F. Oteo Dominguez; Maria R. Ortas-Nadal; Eduardo Molina Navarro; Xavier Carrillo; Juan H. Alonso-Briales; Felipe Fernández-Vázquez; Luis Asmarats Serra; Daniel Hernandez-Vaquero; Pilar Jimenez-Quevedo; Dolores Mesa; Tania Rodríguez-Gabella; Ander Regueiro; Amparo Martinez Monzonís; Luisa Salido Tahoces; Lara Ruiz Gomez; Blanca Trejo-Velasco; Victor M. Becerra-Muñoz; Carmen Garrote-Coloma; Estafanía Fernández Peregrina; Rebeca Lorca; Jose A. De Agustín; Miguel Romero; Ignacio J. Amat-Santos; Manel Sabaté; Ana B. Cid Alvarez; Jose M. Hernandez-Garcia; Javier Gualis; Dabit Arzamendi; Cesar Moris; Gabriela Tirado-Conte; Angel Sánchez-Recalde; Rodrigo Estevez-Loureiro
Source
Journal of Clinical Medicine, Vol 9, Iss 6, p 1792 (2020)
Subject
Language
English
ISSN
2077-0383
Abstract
Background: Transcatheter mitral valve repair (TMVR) could improve survival in functional mitral regurgitation (FMR), but it is necessary to consider the influence of left ventricular ejection fraction (LVEF). Therefore, we compare the outcomes after TMVR with Mitraclip® between two groups according to LVEF. Methods: In an observational registry study, we compared the outcomes in patients with FMR who underwent TMVR with and without LVEF 30% (group 2) had similar propensity scores and were included in the analyses. The primary study endpoint was significantlly higher in group 1 (33.3% vs. 9.4%, p = 0.002). There was a maintained improvement in secondary endpoints without significant differences among groups. Conclusion: FMR patients with LVEF ® had higher mortality and readmissions than patients with LVEF ≥30% treated with the same device. However, both groups improved the NYHA functional class and MR severity.